Latest News
LEADING EDGE MATERIALS WELCOMES SWEDISH MINERAL STRATEGY AND POTENTIAL MEASURES TO ACCELERATE STRATEGIC PROJECTS
LEADING EDGE MATERIALS WELCOMES SWEDISH MINERAL STRATEGY AND POTENTIAL MEASURES TO ACCELERATE STRATEGIC PROJECTS Swedish Government identifies mining as a strategic component of national security and
Fractus und Geotab legen US-Patentstreit bei
/PRNewswire/ -- Fractus, ein Pionier auf dem Gebiet der Antennentechnologie und der Patentlizenzierung, gab heute bekannt, dass das Unternehmen eine Einigung
Fractus and Geotab settle U.S. patent litigation
/PRNewswire/ -- Fractus, a pioneer in antenna technology and patent licensing, today announced that it has reached a settlement with Geotab, resolving the
Fractus et Geotab règlent leur litige en matière de brevets aux États-Unis
/PRNewswire/ -- Fractus, pionnière dans le domaine des technologies d'antennes et de la concession de licences de brevets, a annoncé aujourd'hui avoir conclu
Fractus y Geotab resuelven su litigio de patentes en EE. UU.
/PRNewswire/ -- Fractus, empresa pionera en tecnología de antenas y licencias de patentes, anunció hoy que ha llegado a un acuerdo con Geotab, poniendo fin al
Fractus and Geotab settle U.S. patent litigation
/PRNewswire/ -- Fractus, a pioneer in antenna technology and patent licensing, today announced that it has reached a settlement with Geotab, resolving the
VARON Highlights Healthy Breathing Habits and the Return of Its Popular Lung Breathing Trainers
/PRNewswire/ -- As more people prioritize respiratory wellness, simple breathing exercises have become an accessible way to support healthy breathing habits
Monport MEGAS Brings Advanced LightBurn Features to Desktop CO2 Laser Engraving
/PRNewswire/ -- As LightBurn continues to be the preferred software for makers, educators, and small manufacturing businesses, Monport is emphasizing the
SLB: A Stronger 2027 Is Not Fully Priced In
SLB is rated Buy, with a base case of 30% upside plus a 2.25% dividend, grounded in normalized multiples on 2027 earnings. Q2 results were mixed year-on-year but sequentially strong, with revenue up
Nucor Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Nucor Corporation (NYSE:NUE) will release its second quarter earnings report after the closing bell on Monday, July 27.
FIVA: Ex-U.S. Developed Markets ETF With A Tilt To Financials
Fidelity International Value Factor ETF offers low-cost, value-focused exposure to ex-US developed markets, emphasizing large and mega caps with a European tilt. FIVA has outperformed the ex-US benchm
Esquire Financial: Earnings Accelerate Ahead Of Deal Completion
Esquire Financial Holdings earns a "Buy" rating following a faster pace of earnings growth in 2Q2026 and the impending completion of a value-accretive acquisition. ESQ's litigation-linked loan book su
F1R3FLY Joins the Tata Consultancy Services Alliance Ecosystem, Bringing Concurrent, Mathematically Secure Computing to TCS's Global Enterprise Client Base
/PRNewswire/ -- F1R3FLY Limited ("F1R3FLY"), the London-headquartered developer of the rho-calculus concurrent-computing platform, announced that it has joined
Mercor is embracing old-school Big Tech interview strategies that even Google and Microsoft are ditching
Mercor's interview strategy diverges from what most of Silicon Valley is moving toward. Mercor prioritizes whiteboarding interviews, which became widespread in the 2010s.
Bexil Investment Trust: A Deeply Discounted Fund Without An Escape Hatch
Bexil Investment Trust trades at a 38% discount to NAV, but structural issues limit value realization. The fund's portfolio is concentrated in publicly traded equities, with the top 10 holdings making
Trump just restarted the global trade war — but here's why his new tariff blitz is very different
The Trump administration on Friday unveiled new tariffs on 60 trading partners, reigniting global trade tensions. The new duties land in a markedly different economic environment from last year's 'Lib
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline
Transaction builds on argenx's prior strategic investment in Forte Biosciences and reflects a disciplined approach to accessing novel biology that can fuel long-term growth FB102 Phase 1b studies in v
ClearView Wealth Limited (CVWLF) Shareholder/Analyst Call Transcript
ClearView Wealth Limited (CVWLF) Shareholder/Analyst Call Transcript
EIPI: Light Enough For Upside, Heavier For The Grind - Maintain Buy
FT Energy Income Partners Enhanced Income ETF (EIPI) remains a Buy, supported by structural demand in LNG exports and AI-driven power needs. EIPI's flexible option layer, recently increased to 36% co
Gildan Investor News: If You Have Suffered Losses in Gildan Activewear Inc. (NYSE: GIL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Gildan Activewear